Your browser doesn't support javascript.
loading
Diagnosis of a case with oculocutaneous albinism type Ⅲ with next generation exome capture sequencing / 中华医学遗传学杂志
Chinese Journal of Medical Genetics ; (6): 73-77, 2017.
Article in Chinese | WPRIM | ID: wpr-345321
ABSTRACT
<p><b>OBJECTIVE</b>To explore the clinical and genetic features of a Chinese boy with oculocutaneous albinism.</p><p><b>METHODS</b>The clinical features of the patient were analyzed. The DNA of the patient and his parents was extracted and sequenced by next generation exome capture sequencing. The nature and impact of detected mutation were predicted and validated.</p><p><b>RESULTS</b>The child has displayed strabismus, poor vision, nystagmus and brown hair. DNA sequencing showed that the patient has carried compound heterozygous mutations of the TYRP1 gene, namely c.1214C>A (p.T405N) and c.1333dupG, which were inherited from his mother and father, respectively. Neither mutation was reported previously.</p><p><b>CONCLUSION</b>The child has suffered from oculocutaneous albinism type Ⅲ caused by mutations of the TYRP1 gene.</p>
Subject(s)
Full text: Available Index: WPRIM (Western Pacific) Main subject: Oxidoreductases / Parents / Membrane Glycoproteins / Base Sequence / Family Health / Albinism, Oculocutaneous / Amino Acid Sequence / Diagnosis / High-Throughput Nucleotide Sequencing / Exome Type of study: Diagnostic study / Prognostic study Limits: Child, preschool / Female / Humans / Male Language: Chinese Journal: Chinese Journal of Medical Genetics Year: 2017 Type: Article

Similar

MEDLINE

...
LILACS

LIS

Full text: Available Index: WPRIM (Western Pacific) Main subject: Oxidoreductases / Parents / Membrane Glycoproteins / Base Sequence / Family Health / Albinism, Oculocutaneous / Amino Acid Sequence / Diagnosis / High-Throughput Nucleotide Sequencing / Exome Type of study: Diagnostic study / Prognostic study Limits: Child, preschool / Female / Humans / Male Language: Chinese Journal: Chinese Journal of Medical Genetics Year: 2017 Type: Article